| WKY |
plasma sodium level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood sodium amount |
male |
days
| 7 |
149.0 |
mmol/l |
3.0 |
7.94 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
23 |
days |
100482 |
2479 |
| WKY |
plasma sodium level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood sodium amount |
male |
days
| 8 |
150.0 |
mmol/l |
2.0 |
5.66 |
automated plasma analysis |
0.0 |
|
|
|
100484 |
2479 |
| WKY |
plasma sodium level |
controlled enalapril content drinking water (50 mg/l) (for 30 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood sodium amount |
male |
days
| 5 |
138.0 |
mmol/l |
2.0 |
4.47 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
23 |
days |
100483 |
2479 |
| WKY |
plasma sodium level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood sodium amount |
male |
days
| 9 |
143.0 |
mmol/l |
3.0 |
9.0 |
automated plasma analysis |
0.0 |
|
|
|
100487 |
2479 |
| WKY |
plasma potassium level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood potassium amount |
male |
days
| 7 |
5.9 |
mmol/l |
0.3 |
0.79 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
23 |
days |
100491 |
2479 |
| WKY |
plasma sodium level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood sodium amount |
male |
days
| 9 |
148.0 |
mmol/l |
1.0 |
3.0 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
|
|
100485 |
2479 |
| WKY |
plasma sodium level |
controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood sodium amount |
male |
days
| 9 |
146.0 |
mmol/l |
3.0 |
9.0 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
490 |
days |
100489 |
2479 |
| WKY |
plasma sodium level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood sodium amount |
male |
days
| 9 |
152.0 |
mmol/l |
2.0 |
6.0 |
automated plasma analysis |
0.0 |
|
|
|
100481 |
2479 |
| WKY |
plasma potassium level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood potassium amount |
male |
days
| 8 |
4.3 |
mmol/l |
0.1 |
0.28 |
automated plasma analysis |
0.0 |
|
|
|
100493 |
2479 |
| WKY |
plasma potassium level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood potassium amount |
male |
days
| 9 |
4.6 |
mmol/l |
0.2 |
0.6 |
automated plasma analysis |
0.0 |
|
|
|
100490 |
2479 |
| WKY |
plasma potassium level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood potassium amount |
male |
days
| 8 |
5.0 |
mmol/l |
0.4 |
1.13 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
490 |
days |
100497 |
2479 |
| WKY |
plasma potassium level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood potassium amount |
male |
days
| 9 |
4.4 |
mmol/l |
0.1 |
0.3 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
|
|
100494 |
2479 |
| WKY |
plasma potassium level |
controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood potassium amount |
male |
days
| 9 |
4.7 |
mmol/l |
0.3 |
0.9 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
490 |
days |
100498 |
2479 |
| WKY |
plasma sodium level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood sodium amount |
male |
days
| 8 |
142.0 |
mmol/l |
5.0 |
14.14 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
490 |
days |
100488 |
2479 |
| WKY |
plasma potassium level |
controlled enalapril content drinking water (50 mg/l) (for 30 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood potassium amount |
male |
days
| 5 |
5.8 |
mmol/l |
0.4 |
0.89 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
23 |
days |
100492 |
2479 |
| WKY |
plasma potassium level |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood potassium amount |
male |
days
| 8 |
4.7 |
mmol/l |
0.3 |
0.85 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
|
|
100495 |
2479 |
| WKY |
plasma sodium level |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood sodium amount |
male |
days
| 8 |
148.0 |
mmol/l |
2.0 |
5.66 |
automated plasma analysis |
0.0 |
PA IV 50mg/kg |
|
|
100486 |
2479 |
| WKY |
plasma potassium level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood potassium amount |
male |
days
| 9 |
4.2 |
mmol/l |
0.2 |
0.6 |
automated plasma analysis |
0.0 |
|
|
|
100496 |
2479 |